Glimepiride
Pricing Report NDC 66993-164-02

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Glimepiride (NDC 66993-164-02) is $0.11137 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Oct 15, 2014.

As a provided by Prasco Laboratories, this medication is distributed in a 100 TABLET in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.11137
Per EA

Effective Date
Oct 15, 2014
Billable Units
100 EA
Estimated Package Price
$11.14
Data Status
As of Nov 19, 2014
C/I - Chain or Independent Pharmacy
Package NDC
Description
100 TABLET in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.05211 to $0.11137 per EA. Over this 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.0521 - $0.1114
Market Volatility
113.72% Variance
Latest Trend
102.05%
Date Unit Price Unit Source Method Rate
Oct 15, 2014 $0.11137 EAC/I - Chain or Independent PharmacyCode 3, 6G - Generic
Oct 15, 2014 $0.11137 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Sep 17, 2014 $0.05512 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2014 $0.05570 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 23, 2014 $0.05559 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 18, 2014 $0.05211 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 21, 2014 $0.05598 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 23, 2014 $0.05495 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2014 $0.05813 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2014 $0.05989 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2014 $0.06532 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2013 $0.05873 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 21, 2013 $0.05783 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026